C157H170F2N30O7 — CID 157152208
4-anilino-6-(1-butylpyrazol-4-yl)-N-cyclopropyl-7-fluoroquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-4-yl)-N-cyclopropyl-7-methylquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-4-yl)-N-ethylquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-4-yl)-N-propan-2-ylquinoline-3-carboxamide;4-(benzylamino)-6-(1-butylpyrazol-4-yl)-N-cyclopropyl-7-(hydroxymethyl)quinoline-3-carboxamide;4-(2-bicyclo[1.1.1]pentanylamino)-6-(1-butylpyrazol-4-yl)-N-cyclopropyl-7-fluoroquinoline-3-carboxamide (PubChem CID 157152208) has the molecular formula C157H170F2N30O7 and a molecular weight of 2627.29 g/mol. Its IUPAC name is 4-anilino-6-(1-butylpyrazol-4-yl)-N-cyclopropyl-7-fluoroquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-4-yl)-N-cyclopropyl-7-methylquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-4-yl)-N-ethylquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-4-yl)-N-propan-2-ylquinoline-3-carboxamide;4-(benzylamino)-6-(1-butylpyrazol-4-yl)-N-cyclopropyl-7-(hydroxymethyl)quinoline-3-carboxamide;4-(2-bicyclo[1.1.1]pentanylamino)-6-(1-butylpyrazol-4-yl)-N-cyclopropyl-7-fluoroquinoline-3-carboxamide.
| Compound Name | 4-anilino-6-(1-butylpyrazol-4-yl)-N-cyclopropyl-7-fluoroquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-4-yl)-N-cyclopropyl-7-methylquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-4-yl)-N-ethylquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-4-yl)-N-propan-2-ylquinoline-3-carboxamide;4-(benzylamino)-6-(1-butylpyrazol-4-yl)-N-cyclopropyl-7-(hydroxymethyl)quinoline-3-carboxamide;4-(2-bicyclo[1.1.1]pentanylamino)-6-(1-butylpyrazol-4-yl)-N-cyclopropyl-7-fluoroquinoline-3-carboxamide |
|---|---|
| PubChem CID | 157152208 |
| Molecular Formula | C157H170F2N30O7 |
| Molecular Weight | 2627.29 g/mol |
| Exact Mass | 2625.38 |
| IUPAC Name | 4-anilino-6-(1-butylpyrazol-4-yl)-N-cyclopropyl-7-fluoroquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-4-yl)-N-cyclopropyl-7-methylquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-4-yl)-N-ethylquinoline-3-carboxamide;4-anilino-6-(1-butylpyrazol-4-yl)-N-propan-2-ylquinoline-3-carboxamide;4-(benzylamino)-6-(1-butylpyrazol-4-yl)-N-cyclopropyl-7-(hydroxymethyl)quinoline-3-carboxamide;4-(2-bicyclo[1.1.1]pentanylamino)-6-(1-butylpyrazol-4-yl)-N-cyclopropyl-7-fluoroquinoline-3-carboxamide |
| SMILES | CCCCn1cc(-c2cc3c(NC4C5CC4C5)c(C(=O)NC4CC4)cnc3cc2F)cn1.CCCCn1cc(-c2cc3c(NCc4ccccc4)c(C(=O)NC4CC4)cnc3cc2CO)cn1.CCCCn1cc(-c2cc3c(Nc4ccccc4)c(C(=O)NC4CC4)cnc3cc2C)cn1.CCCCn1cc(-c2cc3c(Nc4ccccc4)c(C(=O)NC4CC4)cnc3cc2F)cn1.CCCCn1cc(-c2ccc3ncc(C(=O)NC(C)C)c(Nc4ccccc4)c3c2)cn1.CCCCn1cc(-c2ccc3ncc(C(=O)NCC)c(Nc4ccccc4)c3c2)cn1 |
| InChI | InChI=1S/C28H31N5O2.C27H29N5O.C26H26FN5O.C26H29N5O.C25H28FN5O.C25H27N5O/c1-2-3-11-33-17-21(15-31-33)23-13-24-26(12-20(23)18-34)29-16-25(28(35)32-22-9-10-22)27(24)30-14-19-7-5-4-6-8-19;1-3-4-12-32-17-19(15-29-32)22-14-23-25(13-18(22)2)28-16-24(27(33)31-21-10-11-21)26(23)30-20-8-6-5-7-9-20;1-2-3-11-32-16-17(14-29-32)20-12-21-24(13-23(20)27)28-15-22(26(33)31-19-9-10-19)25(21)30-18-7-5-4-6-8-18;1-4-5-13-31-17-20(15-28-31)19-11-12-24-22(14-19)25(30-21-9-7-6-8-10-21)23(16-27-24)26(32)29-18(2)3;1-2-3-6-31-13-16(11-28-31)18-9-19-22(10-21(18)26)27-12-20(25(32)29-17-4-5-17)24(19)30-23-14-7-15(23)8-14;1-3-5-13-30-17-19(15-28-30)18-11-12-23-21(14-18)24(29-20-9-7-6-8-10-20)22(16-27-23)25(31)26-4-2/h4-8,12-13,15-17,22,34H,2-3,9-11,14,18H2,1H3,(H,29,30)(H,32,35);5-9,13-17,21H,3-4,10-12H2,1-2H3,(H,28,30)(H,31,33);4-8,12-16,19H,2-3,9-11H2,1H3,(H,28,30)(H,31,33);6-12,14-18H,4-5,13H2,1-3H3,(H,27,30)(H,29,32);9-15,17,23H,2-8H2,1H3,(H,27,30)(H,29,32);6-12,14-17H,3-5,13H2,1-2H3,(H,26,31)(H,27,29) |
| InChIKey | ALJSKDKMIYGZDI-UHFFFAOYSA-N |
| XLogP | 32.33 |
| TPSA | 451.27 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 50 |
| Heavy Atoms | 196 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2627.29 |
| LogP ≤ 5 | 32.33 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 31 |